Abstract 973: Plasma a ndrogen receptor (AR) copy number gain at progression in patients randomized in the STAMPEDE phase 3 abiraterone acetate, prednisolone (AAP) and enzalutamide (ENZ) trial: An ancillary biomarker study
Leone, Gianmarco, Orlando, Francesco, Thakali, Suparna, Lall, Sharanpreet, Wetterskog, Daniel, Wingate, Anna, Clarke, Noel W., James, Nicholas D., Demichelis, Francesca, Attard, Gerhardt
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial
Ruiz-Vico, Maria, Wetterskog, Daniel, Orlando, Francesco, Thakali, Suparna, Wingate, Anna, Jayaram, Anuradha, Cremaschi, Paolo, Vainauskas, Osvaldas, Brighi, Nicole, Castellano-Gauna, Daniel, Åström, Lennart, Matveev, Vsevolod B., Bracarda, Sergio, Esen, Adil, Feyerabend, Susan, Senkus, Elżbieta, López-Brea Piqueras, Marta, Gupta, Santosh, Wenstrup, Rick, Boysen, Gunther, Martins, Karla, Iwata, Kenneth, Chowdhury, Simon, Gourgioti, Georgia, Serikoff, Alexis, Gonzalez-Billalabeitia, Enrique, Merseburger, Axel S., Demichelis, Francesca, Attard, Gerhardt
Published in European urology oncology (10.09.2024)
Published in European urology oncology (10.09.2024)
Get full text
Journal Article